PetIQ Inc

PetIQ — Merger or Acquisition (September 2019)

11 slides from PetIQ's merger presentation, Sep 19, 2019

  1. Slide 1: Perrigo Animal Health Acquisition Pro Forma Financial Information

    Slide 1: Perrigo Animal Health Acquisition Pro Forma Financial Information

    PERRIGO ANIMAL HEALTH ACQUISITION PRO FORMA FINANCIAL INFORMATION SEPTEMBER 19, 2019

  2. Slide 2: Forward-looking statements

    Slide 2: Forward-looking statements

    2 This presentation contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events, including statements regarding the potential benefits and synergies of the acquisition of the Perrigo Animal Healt

  3. Slide 3: Table of Contents

    Slide 3: Table of Contents

    3 TABLE OF CONTENTS •SUMMARY OF ACQUISITION AND OPERATIONAL ADJUSTMENTS •PRO FORMA FINANCIAL DATA • 2018 ADJUSTED PRO FORMA NET SALES AND GROSS PROFIT • 2018 ADJUSTED PRO FORMA ADJUSTED EBITDA RECONCILIATION •APPENDIX •OPERATIONAL ADJUSTMENTS PetIQ | 2019

  4. Slide 4: Summary of Acquisition and Operational Adjustments

    Slide 4: Summary of Acquisition and Operational Adjustments

    4 SUMMARY OF ACQUISITION AND OPERATIONAL ADJUSTMENTS .. Removed sales made under distribution agreement transitioned to PetIQ .. Removed sales of discontinued product lines and lost business .. Adjusted for other non recurring revenue and costs, including overhead differences from historical allocat

  5. Slide 5: Pro Forma Financial Data

    Slide 5: Pro Forma Financial Data

    5 PRO FORMA FINANCIAL DATA* HISTORICAL $ IN MILLIONS PETIQ PAH RECLASS ADJUSTMENTS PRO FORMA NET SALES $528.6 $91.9 ($1.8) $618.7 COST OF SALES $445.3 $65.4 ($1.8) $(20.8) $488.1 GROSS PROFIT $83.3 $26.5 $20.8 $130.6 G&A $72.3 $36.0 $0.3 $108.6 OPERATING INCOME $7.7 ($182.0) $20.4 ($153.8) OTHER INC

  6. Slide 6: Operational Adjustments

    Slide 6: Operational Adjustments

    6 OPERATIONAL ADJUSTMENTS* OPERATIONAL ADJUSTMENTS AS ADJUSTED $ IN MILLIONS PRO FORMA DISTRIBUTION CONTRACT LOST DISTRIBUTION CORPORATE ALLOC NON-RECURRING LEGAL PRO FORMA SALES $618.7 ($6.6) ($8.2) $603.8 COST OF SALES $488.1 ($4.5) ($7.7) $475.9 GROSS PROFIT $130.6 ($2.1) ($0.5) $128.0 G&A $108.6

  7. Slide 7: 2018 Adjusted Sales and Gross Profit

    Slide 7: 2018 Adjusted Sales and Gross Profit

    2018 ADJUSTED PRO FORMA NET SALES AND GROSS PROFIT PetIQ | 2019 ($’S IN MILLIONS) DISTRIBUTION CUSTOMER ADJ Represents the elimination of sales by PAH of products under a distribution agreement that transitioned to PetIQ during 2018. This adjustment resulted in $8.4 million of net sales removed from

  8. Slide 8: 2018 Adjusted Pro Forma Adjusted EBITDA

    Slide 8: 2018 Adjusted Pro Forma Adjusted EBITDA

    2018 ADJUSTED PRO FORMA ADJUSTED EBITDA PetIQ | 2019 $41.5 $41.5 $14.8 ($0.9) $0.01 $2.4 $0.7 $17.0 PRO FORMA ADJ EBITDA DISTRIBUTION CONTRACT DISCONTINUED OPERATIONS CORPORATE ALLOCATIONS NON RECURRING LEGAL PRO FORMA ADJ EBITDA, AS ADJUSTED $56.3 $58.5 DISTRIBUTION CONTRACT DISCONTINUED OPERATIONS

  9. Slide 9: Appendix

    Slide 9: Appendix

    9 APPENDIX PetIQ | 2019

  10. Slide 10: 2018 Pro Forma Adjusted EBITDA Reconciliation

    Slide 10: 2018 Pro Forma Adjusted EBITDA Reconciliation

    10 HISTORICAL $ IN MILLIONS PETIQ PAH RECLASS & ADJUSTMENTS PRO FORMA NET INCOME $0.1 ($168.1) $13.2 ($154.8) INCOME TAXES ($0.7)($13.6) ($5.1) ($19.4) DEPRECIATION AND AMORTIZATION $11.9 $23.4 ($20.4) $14.9 INTEREST $8.0 - $12.4 $20.4 EBITDA $19.3 ($158.3) -($139.0) ACQUISITION & STOCK COMP $9.7 $0

  11. Slide 11: 11

    Slide 11: 11

    11

Source: SEC EDGAR · 8-K filed Sep 19, 2019